Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan

To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression, Anxiety Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders

Sex eligibility

All sexes

Study type

Observational

Primary location

The Islamia University of Bahawalpur, Chak Four Hundred Fifty-four, Punjab Province, Pakistan

About this study

This study is designed to assess the prevalence of depression after the general and smart lockdown in various areas. This study includes both genders of any age.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any individual who can respond to the given questionnaire, with or without any ailment will be included in this study -

Exclusion criteria

Unconcious and non-cooperative individuals

Treatment and study plan

service of questionnaire

Other

Respondents will be given a survey form only and after filling this will be collected back

Primary outcomes

Prevalence estimation of depression in adults

Time frame: study will be completed in 15 days maximum

% prevalence of depression in adult population of south punjab will be assessed

Sponsors and collaborators

Lead sponsor

Islamia University of Bahawalpur

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Oct 27, 2020
Registry last updated: Nov 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed